The star’s Cécred Restoring Hair and Edge Drops have flown off the shelves multiple times since launching earlier this year, ...

Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.

Gene editing could be used to treat millions of glaucoma patients. Glaucoma is a leading cause of blindness, characterized by ...

Perfluorohexyloctane eye drops effectively prepare dry eye patients for cataract surgery by quickly improving symptoms and stabilizing the ocular surface. The drops prevent evaporative tear loss, ...

All eye drop users should check out the FDA's list of 26 different eye drops that could cause infection or even blindness. The FDA has reported that Velocity Pharma manufactured its eye drops under ...

Get ready to be changed "for good," because the trailer for the second "Wicked" film is here. Fans got a "special first look" at the new trailer for "Wicked: For Good" -- the second half of the ...

For readers of a certain age, it may not feel all that long ago when Sheck Wes flirted with household name status on the back of “Mo Bamba,” likely because of the song’s staying power in the years ...

Citi has abandoned a 7-year-old policy restricting firearms sales by its retail clients, the bank said in a statement on its website Tuesday. The move could be read as a bow to increasing pressure ...

“Locking in a CD now can help shield savers from future rate drops. For those concerned about flexibility, a CD laddering strategy, spreading investments across multiple maturities, can offer ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.

Currently, dry eye disease treatment options are limited due to slow therapeutic onset, patient dissatisfaction, and poor adherence. Tryptyr works by stimulating corneal sensory nerves to rapidly ...

MONDAY, June 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of ...